An ethical case that was eventually decided in the US Supreme Court involves the right of patients to request an independent third-party review if their HMO refuses to authorize treatments or procedures deemed medically necessary.
The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.